Adaptilens is a privately held, pre-clinical ophthalmic medical device company based in Chestnut Hill, Massachusetts, developing the Adaptilens A-IOL, described by the company as the first biomimetic accommodating intraocular lens. The soft, flexible lens is built around a patent-protected bottlebrush polymer intended to mimic the young natural crystalline lens, responding to the eye's own ciliary muscles and natural signal to focus so that cataract patients regain near, intermediate and distance vision without glasses. The company raised $1.6M in seed funding led by Pillar VC and a $17.5M Series A led by Perceptive Xontogeny Venture Funds with Pillar VC, 380 Cap and Accanto Partners. Its own site states the Adaptilens is in the development phase and is not yet approved for investigational or commercial use. Adaptilens is a device developer, not a software company, and publishes no developer program, no API documentation and no machine-readable API contract of any kind.
Adaptilens is profiled on the APIs.io network. Tagged areas include Medical Devices, Ophthalmology, Intraocular Lens, Health, and Life Sciences.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/adaptilens: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: adaptilens
name: Adaptilens
description: Adaptilens is a privately held, pre-clinical ophthalmic medical device company based in Chestnut Hill, Massachusetts,
developing the Adaptilens A-IOL, described by the company as the first biomimetic accommodating intraocular lens. The soft,
flexible lens is built around a patent-protected bottlebrush polymer intended to mimic the young natural crystalline lens,
responding to the eye's own ciliary muscles and natural signal to focus so that cataract patients regain near, intermediate
and distance vision without glasses. The company raised $1.6M in seed funding led by Pillar VC and a $17.5M Series A led
by Perceptive Xontogeny Venture Funds with Pillar VC, 380 Cap and Accanto Partners. Its own site states the Adaptilens is
in the development phase and is not yet approved for investigational or commercial use. Adaptilens is a device developer,
not a software company, and publishes no developer program, no API documentation and no machine-readable API contract of
any kind.
url: https://raw.githubusercontent.com/api-evangelist/adaptilens/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-09-07'
modified: '2026-09-07'
tags:
- Medical Devices
- Ophthalmology
- Intraocular Lens
- Health
- Life Sciences
- Biotechnology
- Vision
- Cataract Surgery
- Massachusetts
- Company
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/adaptilens-domain-security.yml
- type: Website
url: https://adaptilens.com/
- type: LinkedIn
url: https://www.linkedin.com/company/adaptilens/
image: https://adaptilens.com/wp-content/uploads/2024/11/Share-Image-1.jpg
x-tier: profiled
x-tier-reason: 'enrichment pass 2026-09-07: full contract discovery run, no public API surface found'
x-enrichment:
date: '2026-09-07'
status: minimal
artifacts_added: 2
pass: local-v3
x-coverage:
state: none
reason: not-a-software-company
detail: Adaptilens is a pre-clinical ophthalmic device developer whose product is a physical implant, the A-IOL accommodating
intraocular lens, and adaptilens.com is a five-page WordPress marketing site that currently returns HTTP 500 with the
body "There has been a critical error on this website" for every path except / and /team/ -- including its own /our-technology/,
/news/ and /contact/ pages, /wp-json/ and every /.well-known/ path -- so there is no developer surface to read and no
host that answers one.
evidence:
- url: https://adaptilens.com/
status: 200
- url: https://adaptilens.com/.well-known/adaptilens-negative-control-4b19cd7e.json
status: 500
- url: https://adaptilens.com/openapi.json
status: 500
- url: https://adaptilens.com/wp-json/
status: 500
- url: https://api.github.com/orgs/adaptilens
status: 404
checked: '2026-09-07'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.